Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.1K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.1K
Skin Cancer01:30

Skin Cancer

5.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.3K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

832
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
832
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.0K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

299
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
299
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

322
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
322

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence for the efficacy and tolerability of an isobutylamido-thiazolyl-resorcinol (Thiamidol)-containing skincare regimen on facial hyperpigmentation and overall skin appearance: A multi-centre study in 11 European countries.

International journal of cosmetic science·2026
Same author

Sun protection advice must include people with skin of colour.

International journal of cosmetic science·2026
Same author

Clinical implications of skincare: lessons from placebo-controlled dermatology trials.

Skin health and disease·2026
Same author

Bilateral nevus of Ota series treated with picosecond laser.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology·2026
Same author

Impact of environmental pollution on acne: a systematic review.

Skin health and disease·2026
Same author

Postinflammatory hyperpigmentation following cutaneous surgery in dark skin types.

Clinical and experimental dermatology·2025

Related Experiment Video

Updated: Nov 24, 2025

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

1.5K

Vitiligo: an update on systemic treatments.

T Searle1, F Al-Niaimi2, F R Ali3

  • 1University of Birmingham, Birmingham, West Midlands, UK.

Clinical and Experimental Dermatology
|December 22, 2020
PubMed
Summary

Systemic treatments like oral corticosteroids and Janus kinase inhibitors are increasingly effective for vitiligo, an autoimmune skin condition. This review examines the evidence for various systemic therapies in managing vitiligo and improving patient outcomes.

More Related Videos

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.3K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.3K

Related Experiment Videos

Last Updated: Nov 24, 2025

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

1.5K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.3K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.3K

Area of Science:

  • Dermatology
  • Autoimmune Diseases
  • Immunology

Background:

  • Vitiligo is an autoimmune skin disorder causing depigmented patches with significant psychosocial effects.
  • Current vitiligo treatments focus on halting disease progression and repigmentation, primarily using topical agents and phototherapy.
  • Systemic therapies are emerging as crucial options for managing vitiligo, either alone or with other treatments.

Purpose of the Study:

  • To review the evidence supporting systemic treatments for vitiligo.
  • To evaluate the efficacy of various systemic agents in managing vitiligo.
  • To provide an overview of emerging systemic treatment options for vitiligo.

Main Methods:

  • Literature review of systemic treatments for vitiligo.
  • Analysis of evidence for oral mini-pulsed corticosteroid therapy.
  • Examination of data on methotrexate, minocycline, ciclosporin, and Janus kinase inhibitors.
  • Inclusion of evidence for certain supplements in vitiligo treatment.

Main Results:

  • Systemic treatments demonstrate significant impact on vitiligo course.
  • Oral mini-pulsed corticosteroids show efficacy in vitiligo management.
  • Methotrexate, minocycline, ciclosporin, and JAK inhibitors are viable systemic options.
  • Supplements are also being explored for their role in vitiligo treatment.

Conclusions:

  • Systemic therapies are increasingly important in vitiligo management.
  • Evidence supports the use of various systemic agents as monotherapy or adjunctive treatment.
  • Further research into systemic treatments can improve vitiligo patient outcomes.